Document Detail


In-vivo and in-vitro sensitivity of Plasmodium falciparum to chloroquine at Indian Oil Corporation, Mathura (U.P.).
MedLine Citation:
PMID:  8319813     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In vivo and in vitro susceptibility of Plasmodium falciparum to chloroquine were conducted at Indian Oil Corporation (IOC), Mathura, India. 18 out of 31 cases showed resistance [minimum inhibitory concentration (MIC) 8 pmol] in in vitro study. EC50 and EC90 values estimated from log-probit analysis for resistant isolates were 0.66 and 1.44 microM/litre, and for sensitive isolates 0.28 and 0.96 microM/litre blood respectively. In vivo tests identified 13 cases (40.62%) as resistant and 19 cases (59.73%) as sensitive out of 32 cases. All the cases belonged to IOC, Mathura complex, or its vicinity.
Authors:
V K Dua; P K Kar; S Kumar; V P Sharma
Related Documents :
16108203 - Understanding genital-shrinking epidemics in west africa: koro, juju, or mass psychogen...
3686593 - Hematocrit and clinical outcome in acute cerebral infarction.
20806583 - Female hydrocele of canal of nuck.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Indian journal of malariology     Volume:  30     ISSN:  0367-8326     ISO Abbreviation:  Indian J Malariol     Publication Date:  1993 Mar 
Date Detail:
Created Date:  1993-08-05     Completed Date:  1993-08-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  17540010R     Medline TA:  Indian J Malariol     Country:  INDIA    
Other Details:
Languages:  eng     Pagination:  29-35     Citation Subset:  IM    
Affiliation:
Malaria Research Centre (Field Station), BHEL Complex, Ranipur, Hardwar, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Chloroquine / pharmacology*,  therapeutic use*
Dose-Response Relationship, Drug
Drug Resistance
Humans
India
Malaria, Falciparum / drug therapy*
Plasmodium falciparum / drug effects*,  growth & development
Chemical
Reg. No./Substance:
54-05-7/Chloroquine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of macrophages in experimental malaria: I. Development of immunobioassay indicators.
Next Document:  Malaria in Shankargarh PHC, Allahabad District (U.P.): a clinical report.